Bain Capital Life Sciences Investors, LLC Q3 2018 Filing

Filed November 14, 2018

Portfolio Value

$440.6B

Holdings

6

Report Date

Q3 2018

Filing Type

13F-HR

All Holdings (6 positions)

#StockSharesValue% PortfolioType
1
—DICERNA PHARMACEUTICALS INC
8,930,237$136.3B30.93%
2
SLDBSOLID BIOSCIENCES INC
1,989,444$93.9B21.30%
3
—APTINYX INC
2,225,092$64.4B14.62%
4
IFRXINFLARX NV
1,764,888$60.6B13.75%
5
REPLREPLIMUNE GROUP INC
2,838,968$45.7B10.37%
6
—MARINUS PHARMACEUTICALS INC
3,977,453$39.8B9.03%